|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study显示文摘 | Olivier Rixe Ronald M Bukowski M Dror Michaelson George Wilding Gary R Hudes Oliver Bolte Robert J Motzer Paul Bycott Katherine F Liau James Freddo Peter C Trask Sinil Kim Brian I Rini | 2007 | Lancet Oncology2007，，： | 2 |
| 2 | Activity of SUl1248, a muhitargeted inhibitor of vascular endothelial growth faclor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 3 | Sunitinib efficacy against advanced renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Rosenberg J | 2007 | J Urol2007，178，5： | 1 |
| 4 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson M D Redman B G | 2006 | J CIin Oncol2006，24，1： | 1 |
| 5 | Activity of SUl1248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor re- ceptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson MD Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 6 | Activity of SUl1248 ,a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson M D Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 7 | The structure of neutrophil defensin genes显示文摘 | Michaelson D Liu L | 1993 | FEBS Lett1993，321，23： | 1 |
| 8 | The structure of neutrophil defensin genes显示文摘 | Linzmeier R Michaelson D Liu L D | 1993 | FEBS Letters1993，321，： | 1 |
| 9 | Activity of SU 11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor,in patients with metastatic renal cell carcinaoma 显示文摘 | MOTZER R J MICHAELSON M D REDMAN B G | 2006 | J Clin Oncol2006，24，1： | 1 |
| 10 | Enhancement of electron emission from near-coalescent nanometer thick continuous diamond films显示文摘 | Ternyak O Michaelson Sh Akhvlediani R | 2006 | Diamond Related Mater2006，15，48： | 1 |
| 11 | Managing menopausal symptoms after gy- necological cancer 显示文摘 | Michaelson R Beller U | 2009 | Current Opinion in Oncol2009，21，： | 1 |
| 12 | Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor, in patients with metastatic renal cell carcinoma显示文摘 | Motzer R J Michaelson D Redman BG | 2006 | J Clin Oncol2006，24，1： | 1 |
| 13 | Activity of SU11248, multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘 | Motzer R J Michaelson M D Redman B G | 2006 | J Clin Oncol2006，24，1： | 1 |
| 14 | Activity of SUl1248, A Multitargeted Inhibitor of Vascular EndothelialGrowth Factor Receptor and Platelet-derived Growth Factor Receptor, in Patients with Metastatic Renal Cell Carcinoma 显示文摘 | Motzer R J Michaelson M D Redman B G | 2008 | Journal of Clinical Oncology2008，24，1： | 1 |
| 15 | Suo11248,a novel tyrosine kinase inhibitor,shows antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma:results of a phase Ⅱtrial proc显示文摘 | Motzer R J Rini B I Michaelson M D | 2004 | Am Soc Clin Oncol2004，22，： | 1 |
| 16 | Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘 | Motzer R J Hutson T E Tomczak P Michaelson M D Bukowski R M Oudard S | 2009 | J Clin Oncol2009，27，： | 1 |
| 17 | Medical waiver experience at US Air Force Special Operations Command, 1992--2003 显示文摘 | STORMS P R MICHAELSON R BREHM W | 2004 | Aviat Space Environ Med2004，75，12： | 1 |
| 18 | Nuclear EDAF-1-related(NUDR) protein contains a novel DNAbinding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter显示文摘 | Michaelson R J Collard M W Ziemba A J | 1999 | J Biol Chem1999，274，30： | 1 |
| 19 | Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer:a phase Ⅱ study 显示文摘 | RIXE O BUKOWSKI R M MICHAELSON M D | 2007 | Lancet Oncol2007，8，11： | 1 |
| 20 | Activity of SU11248,a multitarget-ed inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor,in patients with metastatic renal cell carcinoma显示文摘 | Motzer R J Michaelson M D Redman B G | 2006 | J CIin Oncol2006，24，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员